E
GDRX icon

Ergoteles’s GoodRx Holdings GDRX Stock Holding History

Ergoteles’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-94,791
Closed -$3.89M – 1369
2021
Q3 		$3.89M Buy
+94,791
New +$3.44M 0.14% 174
2021
Q2 		– Sell
-175,840
Closed -$6.86M – 1559
2021
Q1 		$6.86M Buy
+175,840
New +$7.91M 0.21% 128

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Abdiel Capital Advisors New York $52M AUM 13.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
TCMX
Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

Ergoteles's GDRX Position: Q4 2021 in Review

Ergoteles sold out of GoodRx Holdings (GDRX) in Q4 2021, closing a stake of 94,791 shares — an estimated $3.89M sold.

Ergoteles first reported a position in GDRX in Q1 2021 and held it in 2 quarters. The position peaked at $6.86M in Q1 2021. 216 funds tracked by Wall St. Rank hold GDRX as of Q4 2021.

  • Ergoteles reported no remaining GoodRx Holdings position as of Q4 2021 after selling out during the quarter.
  • Ergoteles sold 94,791 GoodRx Holdings shares in Q4 2021, an estimated $3.89M.
  • Ergoteles first reported a position in GoodRx Holdings in Q1 2021 and held it in 2 quarters.
  • Ergoteles's GoodRx Holdings position peaked at $6.86M in Q1 2021.
  • 216 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2021.

Based on Ergoteles's 13F filing for Q4 2021, filed 14 Feb 2022.